Home > M&A deals 2020 > Boehringer Ingelheim GmbH acquires Northern Biologics, Inc.
Add-on Acquistion · Life Science · May 2020

Boehringer Ingelheim GmbH acquires Northern Biologics, Inc.

On May 14, 2020, Boehringer Ingelheim GmbH acquired Northern Biologics, Inc., a life science company in Ontario, Canada.

Deal at a glance

AnnouncedMay 14, 2020 TypeAdd-on Acquistion TargetNorthern Biologics, Inc. Buyer Boehringer Ingelheim GmbH SectorLife Science LocationOntario, Canada ValueNot disclosed

Target company

Northern Biologics, Inc.
Ontario, Canada
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Boehringer Ingelheim GmbH
Company · 8 deals on record
  • 1st transaction in life science
  • 1st transaction in Canada
8deals, all time
4in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Abexxa Biologics, Inc.Same lead buyer · Sep 2021
Repare Therapeutics, Inc.Same sector and country · Jan 2026
LSK Technologies, Inc.Same sector and country · May 2022
A&L Canada Laboratories, Inc.Same sector and country · May 2022

Questions about this deal

Who acquired Northern Biologics, Inc.?Boehringer Ingelheim GmbH acquired Northern Biologics, Inc. on May 14, 2020.

What type of deal was it?It was a add-on acquistion in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).